CAITLIN GEARY: Open Payments
NPI 1407355969 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 35 payments from 21 companies in 2025. Trend: 2023 $1,173 · 2024 $281 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 6 | $171 |
| Dexcom, Inc. | 2 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Corcept Therapeutics | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
Products named: iLet Bionic Pancreas, Dexcom G6 Transmitter, LEQVIO, Korlym, FREESTYLE LIBRE 3, STRENSIQ, CRENESSITY, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across OH — which companies pay providers there.
